SKI Market

A+| A| A-|

Indian Indices

Sensex

76,264.33 736.38
( 0.97%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

69,318.21 3,298.17
(5.00%)

Nikkei 225

10,435.69 -36.03
(-0.34%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

855.7849313

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

38.33

61327.88

EPS(TTM)

Face Value()

Div & Yield %

56.7

0.12

Back

minal industries ltd

Alphageo (India) reports consolidated net loss of Rs 5.90 crore in the December 2025 quarter

Feb 11,2026

Net Loss of Alphageo (India) reported to Rs 5.90 crore in the quarter ended December 2025 as against net loss of Rs 7.85 crore during the previous quarter ended December 2024. Sales rose 50.90% to Rs 16.84 crore in the quarter ended December 2025 as against Rs 11.16 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	16.84	11.16	51
OPM %	-33.73	-62.63	-
PBDT	-3.55	-6.60	46
PBT	-7.94	-10.00	21
NP	-5.90	-7.85	25

76,264.33 736.38 ( 0.97%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

69,318.21 3,298.17 (5.00%)

10,435.69 -36.03 (-0.34%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)